Jian Zuo
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2024First federal award
$1.6MFederal grants as PI4 awards
4Patents grantedLatest Aug 27, 2024
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
4 awards · $1.6M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 17, 2026 | NIH | SBIR Phase II Therapeutics to prevent aminoglycoside-induced hearing loss | $524K | TING THERAPEUTICS LLC |
| Jul 24, 2025 | NIH | SBIR Phase II Therapeutics to prevent aminoglycoside-induced hearing loss | $524K | TING THERAPEUTICS LLC |
| Nov 19, 2024 | NIH | SBIR Phase II Therapeutics to prevent aminoglycoside-induced hearing loss | $524K | TING THERAPEUTICS LLC |
| Jul 17, 2024 | NIH | SBIR Phase II Therapeutics to prevent aminoglycoside-induced hearing loss | $1 | TING THERAPEUTICS LLC |
5 patents as inventor
- US 11433073TING THERAPEUTICS LLCSep 6, 2022
- US 11766440TING THERAPEUTICS LLCSep 26, 2023
- US 11857551TING THERAPEUTICS LLCJan 2, 2024
- US 12070465TING THERAPEUTICS LLCAug 27, 2024
- US TING THERAPEUTICS LLC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#1,316
Awards as PI#566
Patents#41
Companies
- TING THERAPEUTICS LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.